(Q45866981)

17 December 2017

title

Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression (English)

1 reference

17 December 2017

Gene Therapy for Hemophilia B: Host Immunosuppression Prolongs the Therapeutic Effect of Adenovirus-Mediated Factor IX Expression (English)

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

20 May 2024

0 references

0 references

coagulation factor IX

0 references

0 references

1 reference

1 reference

4

M. A. Kay

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578416

20 May 2024

author name string

B. Fang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578416

20 May 2024

R. C. Eisensmith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578416

20 May 2024

H. Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578416

20 May 2024

R. E. Cross

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578416

20 May 2024

C. N. Landen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578416

20 May 2024

G. Gordon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578416

20 May 2024

D. A. Bellinger

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578416

20 May 2024

M. S. Read

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578416

20 May 2024

P. C. Hu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578416

20 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7578416

20 May 2024

publication date

1 August 1995

1 reference

17 December 2017

full work available at URL

http://www.liebertpub.com/doi/pdf/10.1089/hum.1995.6.8-1039

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

20 May 2024

1 reference

17 December 2017

volume

6

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

1039-1044

1 reference

17 December 2017

Cyclosporine as a new approach to therapy of autoimmune diseases

cites work

1

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease

20 May 2024

3

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo

20 May 2024

5

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver

20 May 2024

6

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

Dose study of the immunosuppression of FK 506 in canine lung allo-transplantation

20 May 2024

7

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

The Immunosuppressant FK506 Inhibits Amino Acid Import in Saccharomyces cerevisiae

20 May 2024

9

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs

20 May 2024

10

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs

20 May 2024

11

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

A New Animal Model for Human Respiratory Tract Disease Due to Adenovirus

20 May 2024

14

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

The murine cellular immune response to adenovirus type 5.

20 May 2024

16

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

Functional analysis of adenovirus-5 host-range deletion mutants defective for transformation of rat embryo cells.

20 May 2024

17

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

The mechanism of action of cyclosporin A and FK506

20 May 2024

18

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

The effects of cyclosporin A on the immune system

20 May 2024

19

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

20 May 2024

20

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

20 May 2024

22

1 reference

https://api.crossref.org/works/10.1089/HUM.1995.6.8-1039

20 May 2024

Identifiers

1 reference

17 December 2017

1 reference

17 December 2017